ACT-05 Present and future of precision-based medicine using cancer genome panels

Background: Two cancer genome panels were approved for use in Japan in 2019, and their application in brain tumors are awaited. We have used CANCERPLEXR and FoundationOne CDx (F1) panels for the realization of precision-based medicine in brain tumors. Patients and methods: From August 2017 to presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsumeda, Manabu, Kanemaru, Yu, On, Jotaro, Saito, Shoji, Tsukamoto, Yoshihiro, Okada, Masayasu, Hiraishi, Tetsuya, Oishi, Makoto, Fujii, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699082/
http://dx.doi.org/10.1093/noajnl/vdaa143.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699082/
http://dx.doi.org/10.1093/noajnl/vdaa143.034

Ejemplares similares